Navigation Links
Global Pharmaceutical Services Company Turns to Glowpoint's OpenVideo™ Cloud
Date:12/6/2011

MURRAY HILL, N.J, Dec. 6, 2011 /PRNewswire/ -- Glowpoint, Inc. (OTCBB: GLOW), a leading global provider of cloud managed video services, today announced that a leading global pharmaceutical services company has signed with Glowpoint to manage its global telepresence deployment.

 

This new Glowpoint customer is the only fully integrated bio and pharmaceutical services provider offering clinical, commercial, consulting and capital solutions. The firm has more than 20,000 employees in 60 countries and helped develop or commercialize all of 2010's top 50 best-selling pharmaceutical products or compounds. The company name is not disclosed in this announcement due to confidentiality requirements.

The company utilizes Polycom OTX immersive telepresence and HDX 9000 high-definition video conferencing systems in its offices throughout the world, including locations in the United States, Singapore, the United Kingdom and China. The firm has invested in telepresence and videoconferencing to provide its globally dispersed management and development teams with the capability to collaborate in real time over high-definition video.

 

Through its OpenVideo™ cloud architecture, Glowpoint is providing 24 x 7 remote monitoring and management services for the company's initial deployment of immersive telepresence rooms in the U.S, Singapore, and the U.K.. This includes daily proactive room sweeps that monitor the health of each telepresence room and identify issues that are resolved before they affect a meeting.

 

In addition, Glowpoint is providing management for multi-purpose videoconferencing rooms on an ad-hoc basis, as they participate in immersive telepresence sessions. Glowpoint also manages the company's on premise video infrastructure and provides video bridging and scheduling services.

 

The engagement is anticipated to grow beyond immersive telepresence as company expands its video communications footprint.

 


 

About Glowpoint

Glowpoint, Inc. (OTCBB: GLOW) provides cloud managed video services that make the delivery of consistently high-quality video conferencing and telepresence service as simple as using the internet, between any technology, network and business. Using our OpenVideo™ cloud architecture, Glowpoint enables organizations of all sizes to adopt business-class video easily, scale instantly and collaborate openly, yet securely across technology boundaries – to realize the full value of visual communications. To learn more please visit www.glowpoint.com.

 

(Logo:  http://photos.prnewswire.com/prnh/20100420/GLOWPOINTLOGO)


 

INVESTOR CONTACT:

Investor Relations

Glowpoint, Inc.

+1 973-855-3411

investorrelations@glowpoint.com

 


'/>"/>
SOURCE Glowpoint, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
3. Directors Forum: PEPFAR and the Global AIDS Response
4. Alfacell Corporation to Present at UBS Global Life Sciences Conference
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
7. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
8. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
9. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
10. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
11. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... February 10, 2016 Demonstrates ... 1 receptor selectivity   1 ... which has entered clinical development as a new ... and schizophrenia.   --> 1 ... has entered clinical development as a new treatment ...
(Date:2/9/2016)... Feb. 9, 2016  Landauer, Inc. (NYSE: LDR ... measurement and monitoring, outsourced medical physics services and high ... its fiscal 2016 first quarter ended December 31, 2015. ... Fiscal 2016 First Quarter Highlights , Revenue of ... quarter of 2015 , Domestic Radiation Measurement services revenues ...
(Date:2/9/2016)... BioSciences, Inc. (NASDAQ: SGMO ), the leader ... quarter and full year 2015 financial results and ... editing," said Edward Lanphier, Sangamo,s president and chief ... leads the therapeutic genome editing field and we ... our ground-breaking genome editing programs through IND enabling ...
Breaking Medicine Technology:
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... AxoGen, Inc. ... will report results for the fourth quarter and full year ended December 31, 2015 ... a conference call and webcast for the investment community following the release at 4:30 ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... measure change in their patients. Research shows that the Goal Attainment Scale (GAS) ... therapists overcome this challenge and learn more about the Goal Attainment Scale, Education ...
(Date:2/10/2016)... Palm Beach, Florida (PRWEB) , ... February 10, ... ... & Country Club) announced that it has been awarded the prestigious Distinguished Emerald ... the World award program conducted by BoardRoom magazine, one of the most respected ...
(Date:2/10/2016)... ... February 10, 2016 , ... The ... 26th: Amateur & Professional Divisions - Time: 7:00pm – 10:00pm | Ticket ... Ticket Prices $30, Social Media: http://www.USPoleSportsFed.org , Facebook: http://www.facebook.com/uspolesportsfederation , ...
(Date:2/10/2016)... ... February 10, 2016 , ... The recreational use of marijuana has been ... still face a lot of restrictions as to where they can smoke pot. ... use” and that cannabis “may not be consumed openly or publicly.” , Given the ...
Breaking Medicine News(10 mins):